With America’s fertility rate at a historic low, a “pronatalist” community has emerged, calling for bigger families and ...

There were churchgoing conservatives and Silicon Valley technologists, parents of five and parents of nine, edgelords in leather jackets and women in Lilly Pulitzer, all sharing a common concern ...

The grandmillennial aesthetic has dominated the design world for the last six years, but recently it‘s gotten a happy, honed-in refresh in style.

Longtime Lilly Pulitzer supporter Cindy Cisler checks out the newly remodeled shop on St. Armands Circle. Lilly Pulitzer St.

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows to some extent with companies including Johnson & Johnson, Pfizer ...

Eli Lilly & Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative to injections.

Eli Lilly, for its part, sells tirzepatide as Mounjaro and Zepbound for diabetes and obesity, respectively. In addition, retatrutide is Lilly’s next-generation weight loss candidate.

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions.

Orforglipron, an experimental treatment Eli Lilly is developing for diabetes and weight loss, hit high marks in the first of several pivotal trials. The daily tablet produced blood-sugar ...